Scancell to attend upcoming conferences
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer, today confirms that it will attend and present at the upcoming conferences listed below. Presentations at these high-profile conferences follow the significant recent progress that Scancell has made in developing its pipeline of innovative immunotherapies to address unmet needs in cancer.
- BIO International Convention, taking place in San Diego, CA from 3-6 June.
Mandeep Sehmi, Head of Business Development, will be attending the conference.
- Antibody Engineering & Therapeutics Europe, taking place in London, UK from 4-6 June.
Bubacarr Gibril Kaira, Antibody Research Scientist at Scancell, will be presenting at the conference.
Mireille Vankemmelbeke, Principal Scientist at Scancell, will also be attending.
Session Title: Fc Engineering and Fc Receptor Function
Title: Unlocking the Unique Potential of AvidiMAb® in Clustering and Signalling
Date and Time: Tuesday 4th June at 5:15pm BST
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.